B-ENT
Review

Pathogenic Variants in the COCH Gene That Lead to Hearing Loss and Vestibular Deficit: Update on DFNA9 and Introducing DFNB110

1.

Department of Otorhinolaryngology and Head & Neck Surgery, Antwerp University Hospital, Edegem, Belgium

2.

Department of Translational Neurosciences, University of Antwerp, Faculty of Medicine and Health Sciences, Belgium

3.

Department of Otorhinolaryngology and Head & Neck Surgery, Jessa Hospital, Hasselt, Belgium

4.

Department of Otorhinolaryngology, Radboud University Medical Center, Nijmegen, The Netherlands

5.

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands

6.

Division of Balance Disorders, Department of ENT, Maastricht University Medical Centre, Maastricht, The Netherlands

7.

Faculty of Physics, Tomsk State University, Tomsk, Russia

8.

Centre of Medical Genetics, University of Antwerp and Antwerp University Hospital, Belgium

9.

StatUa, University of Antwerp, Belgium

B-ENT 2020; 1: -
DOI: 10.5152/B-ENT.2022.21791
Read: 267 Downloads: 115 Published: 20 May 2022

DeaFNess Autosomal Dominant 9 is an autosomal dominant hereditary non-syndromic form of progressive sensorineural hearing loss often associated with vestibular dysfunction. It is caused by over 30 heterozygous pathogenic variants in the COCH gene, which encodes cochlin. The DeaFNess Autosomal Dominant 9 p.Pro51Ser variant is the most prevalent cause of adult-onset hereditary hearing loss in Belgium and leads to severe-to-profound sensorineural hearing loss and bilateral vestibulopathy. The recent discovery of homozygous pathogenic variants in the COCH gene—leading to loss-of-function of cochlin—has resulted in the designation of a new autosomal recessive disorder called DFNB110. Cochlear implantation should be considered as soon as patients no longer benefit from a hearing aid because all carriers show a natural evolution toward deafness, a condition that is associated with a higher risk of accelerated cognitive impairment. Moreover, cochlear implantation candi- dates fulfilling the most recent reimbursement criteria in Belgium have better speech understanding after cochlear implantation when com- pared to the previous reimbursement criteria. Vibrotactile feedback of the gravity vector—provided by a balance belt—can significantly improve balance and mobility for the bilateral vestibulopathy symptoms. A vestibulocochlear implant is a modified research cochlear implantation that— next to capturing hearing—is also able to capture motion. The dominant inheritance pattern and non-haploinsufficiency disease mechanism of DeaFNess Autosomal Dominant 9 indicate that suppressing translation of mutant COCH transcripts has high therapeutic potential, which might even prevent hearing impairment. This review will highlight recent insights and future perspectives related to DeaFNess Autosomal Dominant 9 and DFNB110.

Cite this article as: Van Rompaey V, Gommeren H, Bosmans J, et al. Pathogenic variants in the COCH gene that lead to hearing loss and vestibular deficit: update on DFNA9 and introducing DFNB110. B-ENT 11 May 2022 10.5152/B-ENT.2022.21791 [Epub Ahead of Print]

Files
EISSN 2684-4907